Thursday was a busy day at the U.S. Department of Defense, as the Pentagon announced no fewer than 27 separate contract awards worth a total of $766 million. Among the publicly traded companies winning contracts:
- Gentex Corp. (NASDAQ:GNTX) won a contract worth up to $86.8 million to supply the U.S. Army, Navy, Air Force, and Marine Corps with lightweight, advanced combat helmets through Aug. 30, 2016.
- United Technologies (NYSE:UTX) subsidiary Sikorsky was awarded a $25.6 million contract modification hiring it to overhaul 250 Army UH-60 Blackhawk main rotor blades.
- Philips Healthcare, a subsidiary of Koninklijke Philips N.V.
(NYSE:PHG), won a $17.1 million contract modification tasking it with maintaining biomedical equipment at various Air Force and Army military treatment facilities.
- Johnson & Johnson (NYSE:JNJ) was awarded the third (out of seven possible) option-year exercise on a contract to supply various medical and surgical products to the U.S. Army, Navy, Air Force, Marine Corps, and federal civilian agencies. This contract is worth $9.6 million to J&J, and now runs through Aug. 30, 2014.
- Raytheon (NYSE:RTN) won a $7.4 million option exercise on a contract to supply the U.S. Air Force with additional Lot 13 AIM-9X Sidewinder missiles. This contract is due to be completed by August 2015.
Fool contributor Rich Smith has no position in any stocks mentioned. The Motley Fool recommends Gentex and Johnson & Johnson. The Motley Fool owns shares of Gentex, Johnson & Johnson, and Raytheon Company. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
More from The Motley Fool
3 Dividend Stocks That Pay Out Over $8 Billion a Year
Can these huge companies keep the big dividend bucks flowing?
Johnson & Johnson Aims to Start 2018 Healthy
Investors have high hopes for the healthcare conglomerate.
Is Johnson & Johnson a Buy?
Is now a good time to invest in the healthcare titan's stock?